# VYXEOS
> **NDA209401** · New Drug Application · Sponsor: JAZZ PHARMS THERAP · Approved 2017-08-03
## Drug
- **FDA Application Number:** NDA209401
- **Application type:** New Drug Application
- **Brand name:** VYXEOS
- **Generic name:** (DAUNORUBICIN AND CYTARABINE) LIPOSOME
- **Active ingredients:** CYTARABINE; DAUNORUBICIN
- **Dosage form:** POWDER
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** JAZZ PHARMS THERAP
- **Manufacturer:** Jazz Pharmaceuticals, Inc.
- **First approval:** 2017-08-03
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209401)
---
*MORVS · CC0 1.0*